Deutsche Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-89,736
Closed -$273K 3623
2024
Q4
$273K Buy
89,736
+27,042
+43% +$82.2K ﹤0.01% 2923
2024
Q3
$325K Buy
62,694
+25,633
+69% +$133K ﹤0.01% 2642
2024
Q2
$95.2K Sell
37,061
-8,368
-18% -$21.5K ﹤0.01% 3092
2024
Q1
$224K Buy
45,429
+1,127
+3% +$5.55K ﹤0.01% 2730
2023
Q4
$389K Sell
44,302
-740
-2% -$6.51K ﹤0.01% 2457
2023
Q3
$517K Buy
45,042
+5,200
+13% +$59.6K ﹤0.01% 2129
2023
Q2
$1.01M Sell
39,842
-17,676
-31% -$447K ﹤0.01% 1976
2023
Q1
$1.85M Sell
57,518
-100,801
-64% -$3.25M ﹤0.01% 1729
2022
Q4
$2.92M Buy
158,319
+125,982
+390% +$2.33M ﹤0.01% 1448
2022
Q3
$873K Sell
32,337
-8,616
-21% -$233K ﹤0.01% 2046
2022
Q2
$566K Sell
40,953
-4,809
-11% -$66.5K ﹤0.01% 2501
2022
Q1
$892K Sell
45,762
-4,898
-10% -$95.5K ﹤0.01% 2416
2021
Q4
$827K Buy
50,660
+2,764
+6% +$45.1K ﹤0.01% 2538
2021
Q3
$1.33M Sell
47,896
-14,791
-24% -$412K ﹤0.01% 2416
2021
Q2
$1.86M Sell
62,687
-76,766
-55% -$2.28M ﹤0.01% 2292
2021
Q1
$3.9M Buy
139,453
+89,178
+177% +$2.49M ﹤0.01% 1689
2020
Q4
$1.42M Buy
50,275
+12,517
+33% +$355K ﹤0.01% 2176
2020
Q3
$949K Sell
37,758
-96,809
-72% -$2.43M ﹤0.01% 2219
2020
Q2
$3.29M Sell
134,567
-41,295
-23% -$1.01M ﹤0.01% 1516
2020
Q1
$2.6M Buy
175,862
+20,150
+13% +$298K ﹤0.01% 1558
2019
Q4
$2.53M Buy
155,712
+124,438
+398% +$2.02M ﹤0.01% 1823
2019
Q3
$404K Sell
31,274
-474,262
-94% -$6.13M ﹤0.01% 2758
2019
Q2
$6.56M Buy
505,536
+34,789
+7% +$451K ﹤0.01% 1630
2019
Q1
$7.42M Buy
470,747
+138,927
+42% +$2.19M ﹤0.01% 1571
2018
Q4
$6.68M Buy
331,820
+98,257
+42% +$1.98M ﹤0.01% 1554
2018
Q3
$5.8M Sell
233,563
-63,957
-21% -$1.59M ﹤0.01% 2058
2018
Q2
$8.17M Buy
297,520
+129,781
+77% +$3.56M ﹤0.01% 1914
2018
Q1
$5.17M Buy
167,739
+39,251
+31% +$1.21M ﹤0.01% 2178
2017
Q4
$4.59M Buy
128,488
+14,012
+12% +$501K ﹤0.01% 2084
2017
Q3
$3.15M Sell
114,476
-2,664
-2% -$73.4K ﹤0.01% 2208
2017
Q2
$3.09M Buy
117,140
+100,595
+608% +$2.65M ﹤0.01% 2256
2017
Q1
$343K Sell
16,545
-7,412
-31% -$154K ﹤0.01% 3188
2016
Q4
$494K Buy
23,957
+4,551
+23% +$93.8K ﹤0.01% 3097
2016
Q3
$313K Sell
19,406
-2,778
-13% -$44.8K ﹤0.01% 3314
2016
Q2
$300K Buy
22,184
+9,793
+79% +$132K ﹤0.01% 3454
2016
Q1
$215K Buy
12,391
+6,782
+121% +$118K ﹤0.01% 3524
2015
Q4
$190K Sell
5,609
-17,707
-76% -$600K ﹤0.01% 3598
2015
Q3
$692K Sell
23,316
-54,210
-70% -$1.61M ﹤0.01% 3116
2015
Q2
$2.48M Buy
77,526
+37,759
+95% +$1.21M ﹤0.01% 2270
2015
Q1
$823K Buy
39,767
+32,354
+436% +$670K ﹤0.01% 2937
2014
Q4
$125K Sell
7,413
-3,119
-30% -$52.6K ﹤0.01% 4299
2014
Q3
$203K Sell
10,532
-3,147
-23% -$60.7K ﹤0.01% 3875
2014
Q2
$464K Buy
13,679
+11,929
+682% +$405K ﹤0.01% 3417
2014
Q1
$55K Buy
+1,750
New +$55K ﹤0.01% 4473